ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,717 | -99.9% | 67,587 | +44.2% | 0.03% | -18.2% |
| Q3 2022 | $1,549,000 | +109.0% | 46,875 | +122.6% | 0.03% | +73.7% |
| Q2 2022 | $741,000 | -60.9% | 21,058 | -48.9% | 0.02% | -56.8% |
| Q1 2022 | $1,897,000 | +272.7% | 41,244 | +571.7% | 0.04% | +340.0% |
| Q2 2021 | $509,000 | -77.9% | 6,140 | -82.3% | 0.01% | -78.3% |
| Q1 2021 | $2,301,000 | +813.1% | 34,698 | +296.9% | 0.05% | +100.0% |
| Q1 2020 | $252,000 | -4.2% | 8,742 | +110.5% | 0.02% | +91.7% |
| Q4 2019 | $263,000 | +45.3% | 4,152 | -91.5% | 0.01% | +140.0% |
| Q4 2017 | $181,000 | +123.5% | 49,069 | +162.9% | 0.01% | +150.0% |
| Q3 2017 | $81,000 | -68.7% | 18,664 | -86.7% | 0.00% | -75.0% |
| Q1 2017 | $259,000 | -45.4% | 139,900 | -54.3% | 0.01% | -33.3% |
| Q4 2016 | $474,000 | – | 305,857 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |